News - Gene Logic Inc.
Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
Gene Logic Inc. (NASDAQ:GLGC) announced today that the Company's shareholders have approved both the sale of its Genomics Assets to Ocimum Biosolutions and the renaming of the Company as Ore Pharmaceuticals Inc.
Gene Logic Inc. (NASDAQ:GLGC) announced today that Bethany Mancilla has been promoted to Senior Vice President, Business Development, to lead the Company's partnering and licensing efforts. Since July 2004, Ms.
Gene Logic Inc. (NASDAQ: GLGC) announced today recognition of a collaboration milestone, triggered by the filing of a patent application for a new use of an existing Pfizer drug candidate to treat solid tumors.
